We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$15.1B
AUM Growth
+$2.22B
Cap. Flow
+$548M
Cap. Flow %
3.64%
Top 10 Hldgs %
28.62%
Holding
2,384
New
671
Increased
477
Reduced
577
Closed
562

Sector Composition

Rank Sector Weight
1 Industrials 11.79%
2 Technology 9.94%
3 Financials 9.21%
4 Consumer Discretionary 9.02%
5 Healthcare 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWAV
1301
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$476K ﹤0.01%
+2,500
New +$472K
HAYW icon
1302
Hayward Holdings
HAYW
$3.36B
$476K ﹤0.01%
35,000
-1,462,810
-98% -$18M
TU icon
1303
Telus
TU
$15.7B
$475K ﹤0.01%
26,677
-595,319
-96% -$10.3M
DINO icon
1304
HF Sinclair
DINO
$14.5B
$474K ﹤0.01%
+8,529
New +$465K
SNX icon
1305
TD Synnex
SNX
$20.4B
$473K ﹤0.01%
+4,400
New +$432K
SRCL
1306
DELISTED
Stericycle Inc
SRCL
$468K ﹤0.01%
+9,440
New +$424K
TPH
1307
DELISTED
Tri Pointe Homes
TPH
$467K ﹤0.01%
+13,190
New +$383K
RPRX icon
1308
Royalty Pharma
RPRX
$25.3B
$466K ﹤0.01%
16,594
+5,757
+53% +$158K
TKR icon
1309
Timken Company
TKR
$9.02B
$465K ﹤0.01%
5,800
-5,333
-48% -$392K
INZY
1310
DELISTED
Inozyme Pharma
INZY
$463K ﹤0.01%
108,700
-203,180
-65% -$722K
RNW icon
1311
ReNew
RNW
$2.24B
$463K ﹤0.01%
+60,400
New +$372K
PTON icon
1312
Peloton Interactive
PTON
$2.49B
$461K ﹤0.01%
+75,680
New +$408K
XFOR icon
1313
X4 Pharmaceuticals
XFOR
$452M
$461K ﹤0.01%
18,310
-1,225
-6% -$29.8K
TARO
1314
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$459K ﹤0.01%
10,992
+4,492
+69% +$166K
HEI icon
1315
HEICO Corp
HEI
$50.9B
$457K ﹤0.01%
+2,554
New +$432K
LNW
1316
DELISTED
Light & Wonder
LNW
$457K ﹤0.01%
+5,560
New +$446K
TGLS icon
1317
Tecnoglass Holdings Inc.
TGLS
$1.98B
$455K ﹤0.01%
+9,955
New +$360K
SAGE
1318
DELISTED
Sage Therapeutics
SAGE
$455K ﹤0.01%
20,992
-108,427
-84% -$2.15M
GNTX icon
1319
Gentex
GNTX
$5.06B
$451K ﹤0.01%
13,810
-25,134
-65% -$776K
CIM
1320
Chimera Investment
CIM
$1.01B
$451K ﹤0.01%
+30,117
New +$454K
LAND
1321
Gladstone Land Corp
LAND
$362M
$451K ﹤0.01%
31,200
+500
+2% +$7.12K
INDB icon
1322
Independent Bank
INDB
$3.99B
$451K ﹤0.01%
+6,850
New +$378K
GTES icon
1323
Gates Industrial Corporation Ltd.
GTES
$7.3B
$448K ﹤0.01%
33,400
-189,541
-85% -$2.24M
WMB icon
1324
Williams Companies
WMB
$86.7B
$447K ﹤0.01%
+12,820
New +$450K
LPX icon
1325
Louisiana-Pacific
LPX
$5.54B
$446K ﹤0.01%
6,301
-128,419
-95% -$7.67M

Similar funds

Schonfeld Strategic Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Schonfeld Strategic Advisors held 2,384 positions worth $15.1B, up 17% from $12.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Schonfeld Strategic Advisors deployed $548M of net new capital in Q4 2023, opening 671 new positions and adding to 477 existing holdings. Its largest new stake was Equifax: 214,316 shares worth $53M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Union Pacific, an estimated $115M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2023 buy was Equifax: 214,316 shares worth $53M.
  • Schonfeld Strategic Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.67B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2023 reduction was Union Pacific, cutting an estimated $115M.
  • Schonfeld Strategic Advisors fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2023, selling an estimated $94.5M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 29% of its $15.1B portfolio in Q4 2023.
  • Schonfeld Strategic Advisors opened 671 new positions and closed 562 in Q4 2023.
  • Schonfeld Strategic Advisors's portfolio value rose 17% quarter-over-quarter to $15.1B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.